ArticleCancer immunology, immunotherapy : CII2023

αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade.

Mingzhu Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.